GoodCap Pharmaceuticals Inc.: GoodCap Pharmaceuticals and the University of Toronto Awarded NSERC Alliance Grant for Ongoing Research of Low-Dose Psilocybin Drug Formulas Targeting Inflammation and Depressive Disorders
Toronto, Ontario--(Newsfile Corp. - November 10, 2022) - GoodCap Pharmaceuticals Inc. ("GoodCap" or the "Company"), a biopharmaceutical company developing low-dose psychedelic therapies, is pleased to